DRX DLY S&P Biotech Bull 3XETF
13F holders, Q3 2024 (September 30)4holders −1
0new positions
1sold out
$128.65avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Parallel Advisors, LLC ($84K), Lindbrook Capital, LLC ($52K) and Cornerstone Planning Group LLC ($4K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q3 2024)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q2 2024 → Q3 2024: 6 shares bought and 504 shares sold, net −498 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Parallel Advisors, LLC | 0.00% | Reduce -40.5% | 655 | $84K |
| Lindbrook Capital, LLC | 0.00% | Reduce -8.6% | 405 | $52K |
| Cornerstone Planning Group LLC | 0.00% | Reduce -2.8% | 35 | $4K |
| Hollencrest Capital Management | 0.00% | Add +60.0% | 16 | $2K |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.